Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Mar 6;12(3):598.
doi: 10.3390/polym12030598.

Progress in Polymeric Nano-Medicines for Theranostic Cancer Treatment

Imran Ali  1   2 , Mosa Alsehli  1 , Luciana Scotti  3 , Marcus Tullius Scotti  3 , Shang-Ting Tsai  4   5 , Ruei-Siang Yu  4   6 , Ming Fa Hsieh  4   5 , Jung-Chih Chen  7
Affiliations
Review

Progress in Polymeric Nano-Medicines for Theranostic Cancer Treatment

Imran Ali et al. Polymers (Basel). .

Abstract

Cancer is a life-threatening disease killing millions of people globally. Among various medical treatments, nano-medicines are gaining importance continuously. Many nanocarriers have been developed for treatment, but polymerically-based ones are acquiring importance due to their targeting capabilities, biodegradability, biocompatibility, capacity for drug loading and long blood circulation time. The present article describes progress in polymeric nano-medicines for theranostic cancer treatment, which includes cancer diagnosis and treatment in a single dosage form. The article covers the applications of natural and synthetic polymers in cancer diagnosis and treatment. Efforts were also made to discuss the merits and demerits of such polymers; the status of approved nano-medicines; and future perspectives.

Keywords: approved nano-medicines; future perspectives; merits and demerits; polymeric nanoparticles; theranostic cancer treatment.

PubMed Disclaimer

Conflict of interest statement

There is no conflict of interest for this manuscript.

Figures

Figure 1
Figure 1
The schematic representation of polymeric nano-partcles (NPs) theranostic approach.
Figure 2
Figure 2
The different types of polymeric NPs as carriers for drugs delivery.
Figure 3
Figure 3
The timeline of the development of polymeric NPs based drugs for cancer treatment [79].
Figure 4
Figure 4
Numbers of the patents on the different types of NP-based drugs deliver systems.
See this image and copyright information in PMC

References

    1. Bray F., Ferlay J., Soerjomataram I., Siegel R.L., Torre L.A., Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2018;68:394–424. doi: 10.3322/caac.21492. - DOI - PubMed
    1. Aboul-Enein H.Y., Ali I. Determination of tadalafil in pharmaceutical preparation by HPLC using monolithic silica column. Talanta. 2004;65:276–280. doi: 10.1016/j.talanta.2004.06.012. - DOI - PubMed
    1. Ali I., Gaitonde V.D., Aboul-Enein H.Y., Hussain A. Chiral separation of β-adrenergic blockers on cellucoat column by HPLC. Talanta. 2009;78:458–463. doi: 10.1016/j.talanta.2008.11.043. - DOI - PubMed
    1. Ali I., Saleem K., Hussain I., Gaitonde V.D., Aboul-Enein H.Y. Polysaccharides chiral stationary phases in liquid chromatography. Sep. Purif. Rev. 2009;38:97–147. doi: 10.1080/15422110802589916. - DOI
    1. Ali I., Gupta V.K., Aboul-Enein H.Y., Prashant S., Bhavtosh S. Role of racemization in optically active drug development. Chirality. 2007;19:453–463. doi: 10.1002/chir.20397. - DOI - PubMed

LinkOut - more resources